In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Medebiotin Drug Master File in Korea (Medebiotin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Medebiotin. The MFDS reviews the Medebiotin KDMF as part of the drug registration process and uses the information provided in the Medebiotin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Medebiotin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Medebiotin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Medebiotin suppliers with KDMF on PharmaCompass.